Globus Medical (GMED)
(Delayed Data from NYSE)
$53.64 USD
+0.58 (1.09%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $53.64 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GMED 53.64 +0.58(1.09%)
Will GMED be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMED
Globus Medical (GMED) Down 5.8% Since Last Earnings Report: Can It Rebound?
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
GMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Here's Why You Should Retain Globus Medical (GMED) Stock Now
Here's Why Globus Medical (GMED) is a Strong Value Stock
Other News for GMED
What's Driving Masimo Corp's Surprising 14% Stock Rally?
From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires
The Latest Analyst Ratings For Globus Medical
Globus Medical just upgraded at BTIG, here's why
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Eli Lilly & Co (LLY) and Globus Medical (GMED)